Participants 70 88 5
 pancreatic cancer
Participants 399 503 5
 in resectable pancreatic cancer patients treated with adjuvant gemcitabine compared with untreated pati
Participants 645 827 7
on. Tissue samples of 162 patients were available for immunohistochemistry on tissue microarrays to evaluate the impact of Î±-SMA expression and stromal density impact on patient out
